Wisniewski Steve J, Hurdle Mark, Erickson Jason M, Finnoff Jonathan T, Smith Jay
Department of Physical Medicine and Rehabilitation, College of Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905(∗).
Department of Physical Medicine and Rehabilitation, College of Medicine, Mayo Clinic, Jacksonville, FL; Pain Medicine, College of Medicine, Mayo Clinic, Jacksonville, FL(†).
PM R. 2014 Jan;6(1):56-60. doi: 10.1016/j.pmrj.2013.08.603. Epub 2013 Aug 31.
To 1) describe and validate an ultrasound-guided ischial bursa injection technique in an unembalmed cadaveric model and 2) to compare the distance between the ischial tuberosity and the sciatic nerve in a hip neutral versus 90° flexed hip position in asymptomatic volunteers.
The first part was a single-blind prospective study. The second part was a prospective cohort study.
An academic institution procedural skills laboratory and outpatient clinic.
The first part of the study involved 1 cadaveric specimen. The second part of the study involved 20 asymptomatic subjects. The mean age of the subjects was 28 years, and the mean (standard deviation) body mass index was 23.2 ± 2.8 kg/m(2) (minimum, 18.3 kg/m(2); maximum, 29.5 kg/m(2)).
In the first part of the study, a single operator completed bilateral ultrasound-guided ischial bursa injections in an unembalmed cadaveric specimen by using diluted colored latex. In the second part of the study, ultrasound was used in 20 asymptomatic volunteer subjects (10 men and 10 women) to measure the distance from the lateral edge of the ischial tuberosity to the sciatic nerve.
The injections were graded for accuracy as follows: accurate (all injectate contained within the ischial bursa), accurate with overflow (injectate within the ischial bursa but also located in adjacent structures other than the needle track), or inaccurate (injectate not within the ischial bursa). The second part of the study measured the distance from the ischial tuberosity to the sciatic nerve with subjects in 2 different positions (prone and side lying with the tested hip flexed to 90°).
Postinjection cadaveric dissections revealed that both ultrasound-guided injections accurately placed liquid latex within the ischial bursae. There was no evidence of injury to surrounding neurovascular structures. Among asymptomatic volunteers, the average distance between the ischial tuberosity and the sciatic nerve increased from 28.4 mm (range, 20.5-38.9 mm) in the neutral position to 41.9 mm (range, 30.9-66.0 mm) with the hip flexed to 90° (average change, 13.5 mm away from the ischial tuberosity; P = .0001).
Ultrasound-guided ischial bursa injections are technically feasible. Flexing the hip to 90° increases the distance between the ischial tuberosity and the sciatic nerve in asymptomatic volunteers, thus potentially resulting in a safer needle trajectory when ischial bursa injections are clinically indicated. Further investigation in clinical settings is warranted to validate these findings.
1)在未防腐的尸体模型中描述并验证超声引导下坐骨滑囊注射技术;2)比较无症状志愿者在髋关节中立位与髋关节屈曲90°时坐骨结节与坐骨神经之间的距离。
第一部分为单盲前瞻性研究。第二部分为前瞻性队列研究。
一所学术机构的操作技能实验室和门诊诊所。
研究的第一部分涉及1个尸体标本。研究的第二部分涉及20名无症状受试者。受试者的平均年龄为28岁,平均(标准差)体重指数为23.2±2.8kg/m²(最小值18.3kg/m²;最大值29.5kg/m²)。
在研究的第一部分,一名操作者通过使用稀释的彩色乳胶在未防腐的尸体标本中完成双侧超声引导下的坐骨滑囊注射。在研究的第二部分,对20名无症状志愿者(10名男性和10名女性)使用超声测量从坐骨结节外侧边缘到坐骨神经的距离。
注射的准确性分级如下:准确(所有注射剂均包含在坐骨滑囊内)、有溢出的准确(注射剂在坐骨滑囊内,但也位于针道以外的相邻结构中)或不准确(注射剂不在坐骨滑囊内)。研究的第二部分测量了受试者在两种不同体位(俯卧位和患侧髋关节屈曲90°的侧卧位)时坐骨结节到坐骨神经的距离。
注射后尸体解剖显示,两次超声引导下的注射均准确地将液体乳胶注入坐骨滑囊内。没有证据表明周围神经血管结构受到损伤。在无症状志愿者中,坐骨结节与坐骨神经之间的平均距离从中立位时的28.4mm(范围20.5 - 38.9mm)增加到髋关节屈曲90°时的41.9mm(范围30.9 - 66.0mm)(平均变化为远离坐骨结节13.5mm;P = 0.0001)。
超声引导下坐骨滑囊注射在技术上是可行的。在无症状志愿者中,将髋关节屈曲至90°会增加坐骨结节与坐骨神经之间的距离,因此当临床需要进行坐骨滑囊注射时,可能会产生更安全的进针轨迹。有必要在临床环境中进行进一步研究以验证这些发现。